Torrent Pharmaceuticals Ltd (TORNTPHARM) Price & Analysis

Compare

3 Followers

TORNTPHARM Stock Chart & Stats

₹3578.85

-₹79.35(-2.33%)

At close: Jan 08 4:00 PM EST

₹3578.85

-₹79.35(-2.33%)

Day’s Range― - ―

52-Week Range₹2,891.45 - ₹4,239.95

Previous CloseN/A

Volume167.59K

Average Volume (3M)7.49K

Market Cap

₹1.38T

Enterprise Value₹1.46T

Total Cash (Recent Filing)₹6.88B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)60.7

Beta0.61

Next Earnings

May 21, 2026

EPS Estimate

24.3

Next Dividend Ex-DateN/A

Dividend Yield0.84%

Share Statistics

EPS (TTM)19.00

Shares Outstanding338,431,850

10 Day Avg. Volume2,743

30 Day Avg. Volume7,494

Financial Highlights & Ratios

PEG Ratio3.66

Price to Book (P/B)14.19

Price to Sales (P/S)9.36

P/FCF Ratio54.58

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong Free Cash Flow GenerationTorrent's high FCF growth (42.48%) and operating cash conversion (>1.0) indicate durable internal cash generation. That cash cushion supports reinvestment, debt reduction, dividends or bolt-on M&A without heavy external financing, improving long-term strategic optionality.

Healthy Balance Sheet And ReturnsA conservative capital structure (D/E ~0.42; equity ~50.6% of assets) plus ROE >25% provides financial flexibility. Lower leverage reduces solvency risk in downturns and enables durable capital allocation for growth, capex and R&D while sustaining shareholder returns.

Diversified Product Mix With Steady Revenue And Margin BaseConsistent revenue growth and a near-50% gross margin reflect durable product economics. Combined with a multi-therapy domestic branded-generic franchise and international presence, Torrent has structural revenue resilience and ability to defend margins across cycles.

Bears Say

Moderate Net Profit MarginDespite strong gross and EBIT margins, net margin (~16.6%) trails, implying expense, tax or SG&A pressure. If operating costs or pricing dynamics worsen, conversion of revenue to net income could stagnate, limiting long-term earnings leverage and shareholder distributions.

Need To Optimize Asset UtilizationCallouts on asset utilization suggest some capex or capacity may be underleveraged. Persistent inefficiencies would reduce returns on assets, constrain scalable margin expansion, and weaken the company's ability to translate top-line growth into proportionate profit growth over time.

Structural Exposure To Generics Pricing And Regulatory RiskTorrent's core branded and generic businesses face enduring pricing pressure, tender volatility and regulatory approval timelines. These industry-structural risks can compress margins, delay launches or limit market access in key regions, reducing revenue visibility over the medium term.

Torrent Pharmaceuticals Ltd News

Torrent Pharma to Shift Registered Office Within Ahmedabad

The latest announcement is out from Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ). Torrent Pharmaceuticals Limited has approved the...

22d ago

Torrent Pharma Raises ₹11,000 Crore via Multi-series Listed NCD Issue

Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ) has provided an update. Torrent Pharmaceuticals Ltd has raised long-term debt capital...

30d ago

Torrent Pharma Clears ₹12,500-Crore Secured NCD Issue on Private Placement

Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ) has shared an announcement. Torrent Pharmaceuticals Ltd has approved the issuance of...

1M ago

Torrent Pharma to Raise Up to ₹12,500 Crore via Secured NCDs on Private Placement Basis

An announcement from Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ) is now available. Torrent Pharmaceuticals Limited has approved the...

1M ago

India Ratings Affirms Torrent Pharma at IND AA+(Stable), Assigns IND A1+ to Commercial Paper

Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ) just unveiled an announcement. Torrent Pharmaceuticals Limited announced that India Ratings and...

2M ago

Torrent Pharmaceuticals Opens Special Window for Physical Share Transfers

The latest announcement is out from Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ). Torrent Pharmaceuticals Ltd has announced a...

3M ago

Torrent Pharmaceuticals Faces GST Penalty, Plans to Appeal

Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ) has shared an update. Torrent Pharmaceuticals Ltd has disclosed that the Joint...

3M ago

Torrent Pharma Secures CCI Approval for J.B. Chemicals Acquisition

An update from Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ) is now available. Torrent Pharmaceuticals Ltd has received approval...

4M ago

Torrent Pharmaceuticals Releases Q1 2025 Financial Results Conference Call Recording

An announcement from Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ) is now available. Torrent Pharmaceuticals Ltd has announced the...

7M ago

Torrent Pharmaceuticals to Acquire Stake in J.B. Chemicals

Torrent Pharmaceuticals Ltd ( ($IN:TORNTPHARM) ) has provided an update. Torrent Pharmaceuticals Limited has announced the execution of...

8M ago

TORNTPHARM FAQ

What was Torrent Pharmaceuticals Ltd’s price range in the past 12 months?

Torrent Pharmaceuticals Ltd lowest stock price was ₹2891.45 and its highest was ₹4239.95 in the past 12 months.

What is Torrent Pharmaceuticals Ltd’s market cap?

Torrent Pharmaceuticals Ltd’s market cap is ₹1.38T.

When is Torrent Pharmaceuticals Ltd’s upcoming earnings report date?

Torrent Pharmaceuticals Ltd’s upcoming earnings report date is May 21, 2026 which is in 92 days.

How were Torrent Pharmaceuticals Ltd’s earnings last quarter?

Torrent Pharmaceuticals Ltd released its earnings results on Feb 13, 2026. The company reported ₹19 earnings per share for the quarter, beating the consensus estimate of ₹18.196 by ₹0.804.

Is Torrent Pharmaceuticals Ltd overvalued?

According to Wall Street analysts Torrent Pharmaceuticals Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Torrent Pharmaceuticals Ltd pay dividends?

Torrent Pharmaceuticals Ltd pays a Notavailable dividend of ₹6 which represents an annual dividend yield of 0.84%. See more information on Torrent Pharmaceuticals Ltd dividends here

What is Torrent Pharmaceuticals Ltd’s EPS estimate?

Torrent Pharmaceuticals Ltd’s EPS estimate is 24.3.

How many shares outstanding does Torrent Pharmaceuticals Ltd have?

Torrent Pharmaceuticals Ltd has 338,431,850 shares outstanding.

What happened to Torrent Pharmaceuticals Ltd’s price movement after its last earnings report?

Torrent Pharmaceuticals Ltd reported an EPS of ₹19 in its last earnings report, beating expectations of ₹18.196. Following the earnings report the stock price went down -0.185%.

Which hedge fund is a major shareholder of Torrent Pharmaceuticals Ltd?

Currently, no hedge funds are holding shares in IN:TORNTPHARM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.